Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Merck scraps development of osteoporosis drug due to stroke risk

Saturday, September 03, 2016

Merck Co Inc said it would stop developing its experimental osteoporosis drug after an independent analysis confirmed the treatment raises the risk of stroke While the drug odanacatib reduces the risk of osteoporotic fractures the increased risk of...

Novo Nordisk's veteran CEO Lars Rebien Sorensen to step down

Friday, September 02, 2016

Novo Nordisks longserving chief executive Lars Rebien Sorensen is to step down early it was announced on Thursday at a time when the worlds largest insulin maker has said it faces increased competition in the US market where it generates about half i...

Third U.S. patent on Teva's MS drug Copaxone invalidated

Friday, September 02, 2016

US patent officials on Thursday invalidated a third patent covering Teva Pharmaceutical Industries billion multiple sclerosis treatment Copaxone after cancelling two other patents on the drug last week The ruling came in a challenge at the US Paten...

Roche's new-drug strategy buoyed by lung-cancer study

Friday, September 02, 2016

Swiss drugmaker Roche Holding AG seeking to expand uses for its drug Tecentriq beyond bladder cancer said on Thursday a study had shown the new immunotherapy helped people with lung cancer live longer than with chemotherapy The worlds biggest maker...

Takeda joins effort to develop Zika vaccine with U.S. funding

Friday, September 02, 2016

Japanese drugmaker Takeda Pharmaceutical Co on Thursday said it is developing a vaccine to prevent the Zika virus which has been linked to severe birth defects and has secured funding from a US government agency Takeda which is also working on vacci...

Plastic Cap Is Crux of Mylan Argument Against Teva’s EpiPen

Thursday, September 01, 2016

The lack of a cheaper version of Mylan NVs EpiPen shot may come down to a dispute between drugmakers over a plastic cap Unlike Mylans onecap EpiPen Teva Pharmaceutical Industries Ltds proposed substitutable generic version has two caps including a r...

GenSight Biologics receives Orphan Drug Designation for GS030 in Retinitis Pigmentosa

Thursday, September 01, 2016

GenSight Biologics a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system today announced that the European Commission based on a favorable recommend...

Allergan and Adamas enter settlement with Amneal Pharmaceuticals

Thursday, September 01, 2016

Allergan and Adamas announce settlement with Amneal related to namzaric patent litigation Adamas will grant amneal a license to market generic versions of namzaric beginning on January Other terms of settlement were not disclosed Under certain ci...

Sunovion Pharma to buy Canada's Cynapsus for $624 million

Thursday, September 01, 2016

Sunovion Pharmaceuticals Inc a unit of Japans Dainippon Sumitomo Pharma Co Ltd said it would buy Canadas Cynapsus Therapeutics Inc CTHTO CYNAO for about million The price of the Canadian drugmakers USlisted shares hit in extended trading on Wednes...

MDxHealth and Teva Pharmaceuticals Sign Distribution Agreement for SelectMDx in Israel

Wednesday, August 31, 2016

MDxHealth SA announced that it has signed a distribution agreement with Teva Pharmaceuticals to offer its SelectMDxTM for Prostate Cancer test to Tevas urology customers throughout Israel Under the terms of the threeyear agreement Teva Pharmaceutica...